ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CGEM vs MGTX // FREE CASH FLOW YIELD

Cullinan Therapeutics Inc. (NASDAQ) VS. MeiraGTx Holdings plc (NASDAQ) • 15-METRIC TALLY: CGEM 3 — MGTX 1
▲ FREE CASH FLOW YIELD LEADER: MGTX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CGEM VS. MGTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CGEM MGTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -17.68% -5.38% -12.30 MGTX /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — 144.60% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 1/9 +1.00 CGEM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.3 38.3 +6.99 CGEM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $994.3M $932.1M $62.2M CGEM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CGEM REV MGTX REV CGEM GROSS % MGTX GROSS % CGEM FCF MGTX FCF
FY 2025 $0 $81.4M — — -$175.8M -$50.2M
FY 2024 $0 $33.3M — — -$145.3M -$109.5M
FY 2023 $0 $14.0M — — -$134.3M -$105.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CGEM // BETA —
MGTX // BETA —